Despite this, these findings allude to a highly coordinated mechanism through which smoking increases the risk of CRC by increasing MYBL2 expression to drive additional plausible CRC targets, culminating in altered DNA damage response and cell cycle pathways. The gene discussed is MYBL2; the disease is colorectal carcinoma.